"Drugs, Generic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
| Descriptor ID |
D016568
|
| MeSH Number(s) |
D26.360
|
| Concept/Terms |
Drugs, Generic- Drugs, Generic
- Drugs, Nonproprietary
- Nonproprietary Drugs
- Generic Drugs
|
Below are MeSH descriptors whose meaning is more general than "Drugs, Generic".
Below are MeSH descriptors whose meaning is more specific than "Drugs, Generic".
This graph shows the total number of publications written about "Drugs, Generic" by people in this website by year, and whether "Drugs, Generic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2012 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drugs, Generic" by people in Profiles.
-
Pilch NA, Sell ML, McGhee W, Venkataramanan R. Important considerations for drugs, nutritional, and herbal supplements in pediatric solid organ transplant recipients. Pediatr Transplant. 2021 02; 25(1):e13881.
-
Bennett CL, Nagai S, Yang YT, Chen BK, Sartor O, Armitage JO. Generic drugs in oncology - Authors' reply. Lancet Oncol. 2017 02; 18(2):e64.
-
Bennett CL, Sartor OA, Armitage JO, Kantarjian H. Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA. Lancet Oncol. 2017 01; 18(1):22-23.
-
Yang YT, Nagai S, Chen BK, Qureshi ZP, Lebby AA, Kessler S, Georgantopoulos P, Raisch DW, Sartor O, Hermanson T, Kane RC, Hrushesky WJ, Riente JJ, Norris LB, Bobolts LR, Armitage JO, Bennett CL. Generic oncology drugs: are they all safe? Lancet Oncol. 2016 Nov; 17(11):e493-e501.
-
Lally MD, Kral MC, Boan AD. Not All Generic Concerta Is Created Equal: Comparison of OROS Versus Non-OROS for the Treatment of ADHD. Clin Pediatr (Phila). 2016 Nov; 55(13):1197-1201.
-
Sen B, Blackburn J, Morrisey M, Becker D, Kilgore M, Caldwell C, Menachemi N. Can increases in CHIP copayments reduce program expenditures on prescription drugs? Medicare Medicaid Res Rev. 2014; 4(2).
-
Molise MC, Maffey AF, Ramos P, Rubinstein F. Original salbutamol versus similar salbutamol in children with asthma exacerbation: a randomized, controlled, double-blind study. Arch Argent Pediatr. 2012 08; 110(4):285-90.
-
Hulbert AL, Pilch NA, Taber DJ, Chavin KD, Baliga PK. Generic immunosuppression: deciphering the message our patients are receiving. Ann Pharmacother. 2012 May; 46(5):671-7.
-
Miller DP, Mansfield RJ, Woods JB, Wofford JL, Moran WP. The impact of drug samples on prescribing to the uninsured. South Med J. 2008 Sep; 101(9):888-93.
-
Harrod VL, Howard T, Abboud MR, Hankins J, Lobo C, Ware RE. Chemical and functional analysis of generic hydroxyurea formulations. Pediatr Hematol Oncol. 2008 Jun; 25(5):423-9.